Schizophrenia Research
Volume 119, Issue 1 , Pages 101-109, June 2010

Healthy lifestyle habits and 10-year cardiovascular risk in schizophrenia spectrum disorders: An analysis of the impact of smoking tobacco in the CLAMORS schizophrenia cohort

  • Julio Bobes

      Affiliations

    • Department of Medicine, Psychiatry Area, University of Oviedo, Centro de Investigación Biomédica en Red de Salud Mental, CIBERSAM, Oviedo, Asturias, Spain
    • Corresponding Author InformationCorresponding author. Departamento de Medicina, Facultad de Medicina, Universidad de Oviedo, c/Juan Clavería, 6, 33006 Oviedo, Asturias, Spain. Tel./fax: +34 985 10 35 53.
  • ,
  • Celso Arango

      Affiliations

    • Department of Psychiatry, Hospital General Universitario Gregorio Marañón, Centro de Investigación Biomédica en Red de Salud Mental, CIBERSAM, Madrid, Spain
  • ,
  • Margarida Garcia-Garcia

      Affiliations

    • Department of Operations, Biometria Clínica CRO, Barcelona, Spain
  • ,
  • Javier Rejas

      Affiliations

    • Health Outcomes Research Department, Medical Unit, Pfizer España, Alcobendas, Madrid, Spain

Received 11 November 2009; received in revised form 5 February 2010; accepted 6 February 2010. published online 11 March 2010.

Abstract 

Aim

We analysed the impact of tobacco smoking over several healthy lifestyle habits along with the impact on 10-years cardiovascular event (CVE) risk in the CLAMORS schizophrenia cohort.

Methods

This analysis was performed within the scope of the CLAMORS study which included consecutive outpatients meeting DSM-IV criteria for schizophrenia spectrum disorder. Beside smoking history, data on usual healthy lifestyle habits included current exercise, saturated fat sparing diet, low-caloric diet, and daily dietary fibre, salt, caffeine and alcohol consumption were recorded. The 10-year CVE risk was calculated with Framingham function.

Results

1704 patients (61.1% male), 18 to 74years were examined. Prevalence of smoking was 54.54% (95% CI: 52.16%–56.90%) significantly higher than in age and sex matched general population subjects, 31.51% (31.49%–31.52%); OR=2.61 (2.37–2.87, p<0.0001). After controlling by confounders smokers showed a 10-year CVE risk excess versus non-smokers of 2.63 (2.16–3.09), p<0.001. Smoking cessation would reduce the likely of high/very high 10-year CVE risk (above 10%) by near 90% [OR=0.10 (0.06–0.18), p<0.0001]. Also, smokers were more likely to consume alcohol daily [4.13 (3.07–5.54), p<0.0001] and caffeine [3.39 (2.72–4.23), p<0.0001] than non-smoker patients with schizophrenia, and less likely to avoid daily consumption of salt [0.58 (0.43–0.78), p<0.0001], saturated fat [0.71 (0.56–0.91), p=0.006], high fibre diet [0.67 (0.53–0.84), p=0.001], or to follow a low-caloric diet [0.63 (0.48–0.81), p<0.0001]. Smokers also were less likely to do exercise habitually [0.62 (0.48–0.82, p=0.001].

Conclusion

Compared with the general population, patients with schizophrenia showed significant higher prevalence of smoking. Smokers who stop smoking would benefit by a near 90% reduction in the likely of 10-year cardiovascular event risk above 10%.

Keywords: Schizophrenia, Outpatients, Lifestyle habits, Smoking tobacco, General population, Cardiovascular risk, Framingham function, Spain

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0920-9964(10)01116-3

doi:10.1016/j.schres.2010.02.1030

Schizophrenia Research
Volume 119, Issue 1 , Pages 101-109, June 2010